{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:37:12Z","timestamp":1761748632708,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Cardiovascular Diseases"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.acvd.2018.10.001","type":"journal-article","created":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T09:43:30Z","timestamp":1540287810000},"page":"621-624","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The best in coronary artery disease management is yet to come"],"prefix":"10.1016","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0788-8092","authenticated-orcid":false,"given":"Denis","family":"Angoulvant","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodora","family":"Bejan-Angoulvant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.acvd.2018.10.001_bib0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.acvd.2017.10.006","article-title":"Innovative invasive management without stent implantation guided by optical coherence tomography in acute coronary syndrome","author":"Souteyrand","year":"2018","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.acvd.2018.10.001_bib0140","doi-asserted-by":"crossref","first-page":"895","DOI":"10.4244\/EIJY14M07_18","article-title":"Invasive management without stents in selected acute coronary syndrome patients with a large thrombus burden: a prospective study of optical coherence tomography guided treatment decisions. E","volume":"11","author":"Souteyrand","year":"2015","journal-title":"EuroIntervention J"},{"key":"10.1016\/j.acvd.2018.10.001_bib0145","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1808788","article-title":"One-Year Outcomes after PCI Strategies in Cardiogenic Shock","author":"Thiele","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2018.10.001_bib0150","article-title":"Immediate complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease treated by primary percutaneous coronary intervention: insights from the ORBI registry","author":"Pimor","year":"2017","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.acvd.2018.10.001_bib0155","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehy658","article-title":"2018 ESC\/EACTS Guidelines on myocardial revascularization","author":"Neumann","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2018.10.001_bib0160","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.jacc.2015.12.048","article-title":"Leukocytes link local and systemic inflammation in ischemic cardiovascular disease: an expanded \u201ccardiovascular continuum.\u201d","volume":"67","author":"Libby","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2018.10.001_bib0165","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1161\/CIRCRESAHA.115.306656","article-title":"From C-Reactive Protein to Interleukin-6 to Interleukin-1: moving upstream to identify novel targets for atheroprotection","volume":"118","author":"Ridker","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.acvd.2018.10.001_bib0170","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2018.10.001_bib0175","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.jacc.2017.12.046","article-title":"Diagnosis of microvascular angina using cardiac magnetic resonance","volume":"71","author":"Liu","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2018.10.001_bib0180","article-title":"Novel Approach for in\u00a0vivo detection of vulnerable coronary plaques using molecular 3-T CMR Imaging with an albumin-binding probe","author":"Engel","year":"2018","journal-title":"Cardiovasc Imaging"},{"key":"10.1016\/j.acvd.2018.10.001_bib0185","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJMoa1805971","article-title":"Coronary CT angiography and 5-year risk of myocardial infarction","volume":"379","author":"Newby","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2018.10.001_bib0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.acvd.2018.04.004","article-title":"Accuracy of cardiac magnetic resonance imaging to rule out significant coronary artery disease in patients with systolic heart failure of unknown aetiology: single-centre experience and comprehensive meta-analysis","author":"Manchuelle","year":"2018","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.acvd.2018.10.001_bib0195","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s10554-011-9926-y","article-title":"CT angiography with cardiac MRI: non-invasive functional and anatomical assessment for the etiology in newly diagnosed heart failure","volume":"28","author":"Hamilton-Craig","year":"2012","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.acvd.2018.10.001_bib0200","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.acvd.2012.01.010","article-title":"French Society of cardiology guidelines for cardiac rehabilitation in adults","volume":"105","author":"Pavy","year":"2012","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.acvd.2018.10.001_bib0205","article-title":"National trends in admission for cardiac rehabilitation after a myocardial infarction in France from 2010 to 2014","author":"Gabet","year":"2017","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.acvd.2018.10.001_bib0210","article-title":"Impact of ambulatory cardiac rehabilitation on cardiovascular outcomes: a long-term follow-up study","author":"Doimo","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2018.10.001_bib0215","doi-asserted-by":"crossref","first-page":"e225","DOI":"10.2196\/jmir.9943","article-title":"Home-based rehabilitation with telemonitoring guidance for patients with coronary artery disease (short-term results of the TRiCH Study): randomized controlled trial","volume":"20","author":"Avila","year":"2018","journal-title":"J Med Internet Res"},{"key":"10.1016\/j.acvd.2018.10.001_bib0220","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2018.10.001_bib0225","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2018.10.001_bib0230","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s12916-015-0459-4","article-title":"Impact of statin therapy on coronary plaque composition: a systematic review and meta-analysis of virtual histology intravascular ultrasound studies","volume":"13","author":"Banach","year":"2015","journal-title":"BMC Med"},{"key":"10.1016\/j.acvd.2018.10.001_bib0235","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/eurheartj\/eht232","article-title":"Long-term impact on healthcare resource utilization of statin treatment, and its cost effectiveness in the primary prevention of cardiovascular disease: a record linkage study","volume":"35","author":"McConnachie","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2018.10.001_bib0240","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(18)31776-8","article-title":"Long-term mortality after blood pressure-lowering and lipid-lowering treatment in patients with hypertension in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Legacy study: 16-year follow-up results of a randomised factorial trial","author":"Gupta","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.acvd.2018.10.001_bib0245","article-title":"Reaching low-density lipoprotein cholesterol treatment targets in stable coronary artery disease: determinants and prognostic impact","author":"Bauters","year":"2017","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.acvd.2018.10.001_bib0250","doi-asserted-by":"crossref","first-page":"144","DOI":"10.4244\/EIJY18M04_1","article-title":"Fourier to odyssey: the end of the journey for lipid-lowering therapy trials? Lessons from recent clinical trials with anti-PCSK9 antibodies","volume":"14","author":"Sabouret","year":"2018","journal-title":"EuroIntervention J"},{"key":"10.1016\/j.acvd.2018.10.001_bib0255","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1016\/j.jacc.2014.10.018","article-title":"Vaccine for atherosclerosis","volume":"64","author":"Shah","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2018.10.001_bib0260","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s40265-018-0915-5","article-title":"Vaccines Targeting PCSK9: a promising alternative to passive immunization with monoclonal antibodies in the management of hyperlipidaemia?","volume":"78","author":"Weisshaar","year":"2018","journal-title":"Drugs"}],"container-title":["Archives of Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213618301487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213618301487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:44:55Z","timestamp":1761745495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875213618301487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S1875213618301487"],"URL":"https:\/\/doi.org\/10.1016\/j.acvd.2018.10.001","relation":{},"ISSN":["1875-2136"],"issn-type":[{"type":"print","value":"1875-2136"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The best in coronary artery disease management is yet to come","name":"articletitle","label":"Article Title"},{"value":"Archives of Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acvd.2018.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}